首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 乙酸(1/1)盐:((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-氨基-3-羟基丙酰胺基)-4-甲基戊酰胺基)-5-胍基戊酰胺基)-5-胍基戊酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酰化合物

乙酸(1/1)盐:((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-氨基-3-羟基丙酰胺基)-4-甲基戊酰胺基)-5-胍基戊酰胺基)-5-胍基戊酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酰化合物

((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-5-guanidinopentanamido)-5-guanidinopentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine--acetic acid (1/1)

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
10mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1366000-58-9

中文名称

乙酸(1/1)盐:((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-氨基-3-羟基丙酰胺基)-4-甲基戊酰胺基)-5-胍基戊酰胺基)-5-胍基戊酰胺基)-3-羟基丙酰胺基)-3-羟基丙酰胺基)-19-(3-氨基-3-氧代丙基)-49-苄基-28-((S)-仲丁基)-34-(羧甲基)-31,40-双(3-胍基丙基)-16-(羟甲基)-10-异丁基-22-甲基-37-(2-(甲硫基)乙基)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-十六氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-十六氮杂环三十五烷-4-羰基)-L-天冬酰-L-丝酰-L-苯丙氨酰-L-精氨酰-L-酪氨酰化合物

英文名称

((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-5-guanidinopentanamido)-5-guanidinopentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine--acetic acid (1/1)

别名

Carperitide,HANP | hANP(99-126) | Human atrial natriuretic peptide | SUN 4936 | SUN 4936h | SUN 4936r

标准英文名

((4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-amino-3-hydroxypropanamido)-4-methylpentanamido)-5-guanidinopentanamido)-5-guanidinopentanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-19-(3-amino-3-oxopropyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31,40-bis(3-guanidinopropyl)-16-(hydroxymethyl)-10-isobutyl-22-methyl-37-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carbonyl)-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine--acetic acid (1/1)

分子式

C129H207N45O41S3

分子量

3140.55

精确分子量

3138.47

SMILES

CC(=O)O.CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O

标准SMILES

CC(O)=O.CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)CNC(=O)[C@H](CC2C=CC=CC=2)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO

用途

Atrial Natriuretic Peptide (ANP) (1-28), human, porcine (Acetate) is a 28-amino acid peptide hormone produced and secreted by the heart in response to cardiac injury and mechanical stretch. It exhibits diuretic, natriuretic, and vasodilatory activities. ANP (1-28) inhibits endothelin-1 secretion stimulated by angiotensin II (Ang II) and thrombin in cultured endothelial cells, including porcine aortic and human umbilical vein endothelial cells, concomitant with an increase in intracellular cyclic GMP (cGMP) levels. It binds with high affinity to glomerular ANP receptors in rat kidneys, stimulating cGMP accumulation without affecting cAMP levels, thereby playing a key role in electrolyte and fluid homeostasis.

InChIKey

NYSSIVMKYRVLPL-SYGLLGJNSA-N

安全信息

SureRoute逆合成路线

1.  1366000-58-9 逆合成路线 1

—
—
ACSJXC283
1366000-58-9
来源: SureRoute

2.  1366000-58-9 逆合成路线 2

—
—
ACSJXC283
1366000-58-9
来源: SureRoute

3.  1366000-58-9 逆合成路线 3

—
—
ACSJXC283
1366000-58-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手